Data from our in vitro, in silico, and in vivo experiments showed that HF exerts antitumor effects against ESCC by inhibiting tumor growth and promoting apoptosis through the PI3K/AKT/mTOR signaling pathway. This evidence concerns the gene MTOR and esophageal squamous cell carcinoma.